|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$232.94 |
$237.64 |
$232.84 |
$235.31 |
372.40K | 04/18/2024 |
$234.67 |
$240.74 |
$234.31 |
$236.93 |
476.30K | 04/19/2024 |
$237.47 |
$238.34 |
$234.86 |
$237.93 |
616.00K | 04/22/2024 |
$238.20 |
$238.55 |
$233.77 |
$234.06 |
552.50K | 04/23/2024 |
$235.23 |
$240.00 |
$234.16 |
$234.47 |
417.10K |
|
United Therapeutics is a biotechnology company. Co. markets and sells four commercial therapies in the U.S. to treat pulmonary arterial hypertension: Tyvaso® (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin® (treprostinil) Injection (Remodulin); Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, which is approved for treatment of high-risk neuroblastoma, and the Remunity® Pump for Remodulin. | |
|
United Therapeutics (UTHR) has the following price history information. Looking back at UTHR historical stock prices for the last five trading days, on April 17, 2024, UTHR opened at $232.94, traded as high as $237.64 and as low as $232.84, and closed at $235.31. Trading volume was a total of 372.40K shares. On April 18, 2024, UTHR opened at $234.67, traded as high as $240.74 and as low as $234.31, and closed at $236.93. Trading volume was a total of 476.30K shares. On April 19, 2024, UTHR opened at $237.47, traded as high as $238.34 and as low as $234.86, and closed at $237.93. Trading volume was a total of 616.00K shares. On April 22, 2024, UTHR opened at $238.20, traded as high as $238.55 and as low as $233.77, and closed at $234.06. Trading volume was a total of 552.50K shares. On April 23, 2024, UTHR opened at $235.23, traded as high as $240.00 and as low as $234.16, and closed at $234.47. Trading volume was a total of 417.10K shares.
UTHR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into United Therapeutics shares, starting with a $10,000 purchase of UTHR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$90.87 |
|
End price/share: |
$234.47 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
158.03% |
|
Average Annual Total Return: |
9.94% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$25,802.99 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/17/2024 | $235.31 | 04/18/2024 | $236.93 | 04/19/2024 | $237.93 | 04/22/2024 | $234.06 | 04/23/2024 | $234.47 |
|
|